This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3114) Diabetes (152) Diabetes Self-Management (463) Hypertension Prevention and Treatment (207)

Published on in Vol 21, No 10 (2019): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15814, first published .
Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis

Authors of this article:

Robert J Nordyke1 Author Orcid Image ;   Kevin Appelbaum2 Author Orcid Image ;   Mark A Berman2 Author Orcid Image
Article Authors Cited by (28) Tweetations (29) Metrics

Robert J Nordyke   1 * , BSc, MSc, PhD ;   Kevin Appelbaum   2 * , BSE ;   Mark A Berman   2 * , BSc, MD

1 Beta6 Consulting Group, LLC, Topanga, CA, United States

2 Better Therapeutics, LLC, San Francisco, CA, United States

*all authors contributed equally

Corresponding Author: